Albemarle Corporation (ALB) valuation
Albemarle P/E ratio history
Albemarle trades at 350.0 times its earnings over the last twelve months and 8.4 times the earnings analysts expect over the next twelve. At its last 8 fiscal year ends its P/E ranged from 9.5 (year to Dec 2022) to 261.0 (year to Dec 2017), with a median of 14.9.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $141.44 | -$5.76 | n/m | — |
| Dec 31, 2024 | $86.08 | -$11.20 | n/m | — |
| Dec 31, 2023 | $144.48 | $13.36 | 10.8 | 7.9 |
| Dec 31, 2022 | $216.86 | $22.84 | 9.5 | 8.3 |
| Dec 31, 2021 | $233.77 | $1.06 | 220.5 | 42.6 |
| Dec 31, 2020 | $147.52 | $3.52 | 41.9 | — |
| Dec 31, 2019 | $73.04 | $5.02 | 14.6 | — |
| Dec 31, 2018 | $77.07 | $6.34 | 12.2 | — |
| Dec 31, 2017 | $127.89 | $0.49 | 261.0 | — |
| Dec 31, 2016 | $86.08 | $5.67 | 15.2 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Albemarle valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| AlbemarleALB | $10.7B | 350.0 | 8.4 | 1.8 |
| CortevaCTVA | $7.67B | — | 10.6 | — |
| CF IndustriesCF | $18.9B | 9.2 | 9.4 | 2.5 |
| DuPontDD | $19.1B | 147.0 | 18.4 | 4.1 |
| Mosaic Company (The)MOS | $5.84B | — | 20.2 | 0.5 |
| LyondellBasellLYB | $22.2B | — | 8.9 | 0.7 |
| International Flavors & FragrancesIFF | $23.7B | 84.6 | 26.1 | 2.4 |
| DowDOW | $25.1B | — | 17.2 | 0.6 |
| PPG IndustriesPPG | $26.6B | 17.1 | 14.1 | 1.6 |
| Peer median | 50.8 | 15.6 | 1.6 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: ALB financials · ALB returns
No forecast, no recommendation. This page describes Albemarle Corporation from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.